-
61por Franssen, Stijn, Holster, Jessica J., Jolissaint, Joshua S., Nooijen, Lynn E., Cercek, Andrea, D’Angelica, Michael I., Homs, Marjolein Y. V., Wei, Alice C., Balachandran, Vinod P., Drebin, Jeffrey A., Harding, James J., Kemeny, Nancy E., Kingham, T. Peter, Klümpen, Heinz-Josef, Mostert, Bianca, Swijnenburg, Rutger-Jan, Soares, Kevin C., Jarnagin, William R., Groot Koerkamp, Bas“…After adjusting for male gender, performance status, baseline hepatobiliary disease, and multifocal disease, the hazard ratio (HR) for HAIP chemotherapy was 0.27 (95% CI 0.19–0.39). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
62por Alcorn, Sara R., Zhou, Xian Chiong, Bojechko, Casey, Rubo, Rodrigo A., Chen, Michael J., Dieckmann, Karin, Ermoian, Ralph P., Ford, Eric C., Kobyzeva, Daria, MacDonald, Shannon M., McNutt, Todd R., Nechesnyuk, Alexey, Nilsson, Kristina, Sjostrand, Hakan, Smith, Koren S., Stock, Markus, Tryggestad, Erik J., Villar, Rosangela C., Winey, Brian A., Terezakis, Stephanie A.“…On multivariable analysis, there were no significant differences in mean vector magnitude by age, gender, performance status, target location, extent of resection, chemotherapy, or steroid or anesthesia use. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
63por Lasiter, Laura, Tymejczyk, Olga, Garrett‐Mayer, Elizabeth, Baxi, Shrujal, Belli, Andrew J., Boyd, Marley, Christian, Jennifer B., Cohen, Aaron B., Espirito, Janet L., Hansen, Eric, Sweetnam, Connor, Robert, Nicholas J., Small, Mackenzie, Stewart, Mark D., Izano, Monika A., Wagner, Joseph, Natanzon, Yanina, Rivera, Donna R., Allen, Jeff“…The adjusted HR for death ranged from 0.80 (95% CI: 0.69, 0.93) to 1.15 (95% CI: 0.71, 1.85), controlling for age, gender, performance status, and smoking status. This study yielded insights regarding data capture, including ability of real‐world data to precisely identify patient populations and the impact of criteria on end points. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
64por Atmaca, Akin, Wirtz, Ralph W, Werner, Dominique, Steinmetz, Kristina, Claas, Silke, Brueckl, Wolfgang M, Jäger, Elke, Al-Batran, Salah-Eddin“…RESULTS: Clinical features like age, gender, performance status, histological subtype and stage were similarly distributed among SNAI2/SLUG positive and negative patients. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
65por Rades, Dirk, Seidl, Daniel, Janssen, Stefan, Bajrovic, Amira, Karner, Katarina, Strojan, Primoz, Schild, Steven E“…Radiochemotherapy regimen plus seven characteristics (age, gender, performance score, tumor site, T-/N-category, histologic grading) were evaluated for locoregional control (LRC), metastases-free survival (MFS) and overall survival (OS). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
66por Bala, Stalin, Gundeti, Sadashivudu, Linga, Vijay Gandhi, Maddali, Lakshmi Srinivas, Digumarti, Raghunadha Rao, Uppin, Shantveer G.“…There was no significant survival difference among the treatment regimen used but the response to I line chemotherapy impacted survival. Female gender, performance status, and nonsquamous histology were significant predictors of OS (P = 0.0443, P = 0.0003, P = 0.048, respectively). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
67por Rades, Dirk, Conde-Moreno, Antonio J., Cacicedo, Jon, Veninga, Theo, Segedin, Barbara, Stanic, Karmen, Rudat, Volker, Schild, Steven E.“…METHODS: Patients receiving 1 × 8 Gy were matched to patients receiving 5 × 4 Gy for age, gender, performance status, tumor type, involved vertebrae, other bone metastases, visceral metastases, interval between tumor diagnosis and MESCC, ambulatory status and time developing motor deficits. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
68por Williet, Nicolas, Saint, Angélique, Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Bechade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Desrame, Jérome, Artru, Pascal, Thirot Bidault, Anne, Le Roy, Bertrand, Pezet, Denis, Phelip, Jean-Marc, Taieb, Julien“…A propensity score based on age, gender, performance status (PS), and presence of liver metastases was used to make groups comparable. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
69por Keek, Simon, Sanduleanu, Sebastian, Wesseling, Frederik, de Roest, Reinout, van den Brekel, Michiel, van der Heijden, Martijn, Vens, Conchita, Giuseppina, Calareso, Licitra, Lisa, Scheckenbach, Kathrin, Vergeer, Marije, Leemans, C. René, Brakenhoff, Ruud H, Nauta, Irene, Cavalieri, Stefano, Woodruff, Henry C., Poli, Tito, Leijenaar, Ralph, Hoebers, Frank, Lambin, Philippe“…Clinical patient features such as age, gender, performance status etc. were collected. Two machine learning methods were chosen for their ability to handle censored data: Cox proportional hazards regression and random survival forest (RSF). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
70por Yuan, Xiao-Shuai, Chen, Wu-Cheng, Lin, Qing-Ren, Liu, Yuan-Jun, Zhu, Yao-Yao, Sun, Xiao-Jiang, Wu, Qiong-Ya, Liu, Jin-Shi, Xu, Ya-Ping“…After patients were matched for age, gender, performance status, tumor characteristics and pulmonary function, no significant differences were observed in 3-year OS (85.4% and 73.3%, P=0.649), CSS (87.2% and 74.9%, P=0.637) and LC (95.6% and 82.1%, P=0.055). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
71Publicado 2018“…METHODS: A total of 68 NSCLC patients in Peking University Third Hospital were eligible for retrospective analysis between April 2008 and April 2015.The pretreatment and posttreatment NLR and PLR in all patients were calculated based on complete blood counts.Potential prognostic factors such as age, gender, performance status, histology, stage, response to chemotherapy, NLR and PLR were analyzed.NLR and PLR were assessed at baseline and during chemotherapy treatment.OS was calculated by the Kaplan-Meier method.Univariate and multivariate Cox regression analyses were performed to determine the associations of the PLR, NLR and clinical features with OS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
72por Renovanz, Mirjam, Hickmann, Anne-Katrin, Nadji-Ohl, Minou, Keric, Naureen, Weimann, Elke, Wirtz, Christian Rainer, Singer, Susanne, Ringel, Florian, Coburger, Jan“…We compared distress and HRQoL by age (≥ 65 vs. < 65 years), gender, performance score, and time since diagnosis using multivariate linear and logistic regressions. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
73por Rades, Dirk, Küchler, Jan, Graumüller, Lena, Abusamha, Abdulkareem, Schild, Steven E., Gliemroth, Jan“…Seventy-nine patients receiving radiotherapy alone were matched to 79 patients assigned to surgery plus radiotherapy (propensity score method) for age, gender, performance score, tumor type, affected vertebrae, other bone or visceral metastases, interval tumor diagnosis to MSCC, time developing motor deficits, and ambulatory status. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
74por Reyes, Michaela A., Probasco, Mark O., Worby, Trina N., Loertscher, Dylan E., Soderbeck, Lyndsey K., Huddleston, Wendy E.“…CONCLUSION: The robustness of results across gender, performance level, sport, cognitive ability, task cognitive load suggest that the inclusion of cognitive training in the design of optimal LE injury prevention programs warrants further study. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
75por Zheng, Zhiqin, Yuan, Xun, Zhou, Yue, Chu, Li, Yang, Xi, Ni, Jianjiao, Chu, Qian, Chu, Xiao, Liu, Yanfei, Zhu, Zhengfei“…Clinical covariates including age, gender, performance status, smoking, metastatic state, response after chemotherapy, and TRT, were included in multivariate regression analysis. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
76por Jacot, W, Quantin, X, Boher, J-M, Andre, F, Moreau, L, Gainet, M, Depierre, A, Quoix, E, Chevalier, T Le, Pujol, J-L“…Apart from 4 prognostic factors shared in common with other stage IV NSCLC patients, whatever the metastatic site (namely sex, age, gender, performance status and serum sodium level) this study discloses 2 determinants specifically resulting from brain metastasis: i.e. the presence of neurological symptoms and a high serum NSE level. …”
Publicado 2001
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
77por Takahashi, Naoki, Iwasa, Satoru, Taniguchi, Hirokazu, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Yamada, Yasuhide“…Relative mRNA values, that is, T/NT ratios, of target genes were calculated and hazard ratios (HRs) for each gene of interest were adjusted for age, gender, performance status, minor RAS mutations and other clinicopathological variables which exhibited P-values<0.1 on the basis of univariate analysis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
78por Parisi, Alessandro, Cortellini, Alessio, Cannita, Katia, Venditti, Olga, Camarda, Floriana, Calegari, Maria Alessandra, Salvatore, Lisa, Tortora, Giampaolo, Rossini, Daniele, Germani, Marco Maria, Boccaccino, Alessandra, Dell’Aquila, Emanuela, Fulgenzi, Claudia, Santini, Daniele, De Tursi, Michele, Tinari, Nicola, Di Marino, Pietro, Lombardi, Pasquale, Roselló Keränen, Susana, Huerta Álvaro, Marisol, Zurlo, Ina Valeria, Corsi, Domenico Cristiano, Emiliani, Alessandra, Zanaletti, Nicoletta, Troiani, Teresa, Vitale, Pasquale, Giampieri, Riccardo, Merloni, Filippo, Occhipinti, Mario Alberto, Marchetti, Paolo, Roberto, Michela, Mazzuca, Federica, Ghidini, Michele, Indini, Alice, Garajova, Ingrid, Zoratto, Federica, Delle Monache, Simona, Porzio, Giampiero, Ficorella, Corrado“…After adjusting for the key covariates (age, gender, performance status, number of metastatic sites and primary tumor side) Bevacizumab-based regimens revealed to be significantly related with a prolonged PFS (HR = 1.44 (95%CI: 1.02–2.03); p = 0.0399) compared to Aflibercept-based regimens, but not with a prolonged OS (HR = 1.47 (95%CI: 0.99–2.17); p = 0.0503). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
79por Taieb, J., Shi, Q., Pederson, L., Alberts, S., Wolmark, N., Van Cutsem, E., de Gramont, A., Kerr, R., Grothey, A., Lonardi, S., Yoshino, T., Yothers, G., Sinicrope, F.A., Zaanan, A., André, T.“…Associations of markers with SAR were analyzed using Cox proportional hazards models adjusted for age, gender, performance status, T stage, N stage, primary tumor location, grade, KRAS status, and timing of recurrence. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
80por Farrugia, Mark, Ma, Sung Jun, Hennon, Mark, Nwogu, Chukwumere, Dexter, Elisabeth, Picone, Anthony, Demmy, Todd, Yendamuri, Sai, Yu, Han, Fung-Kee-Fung, Simon, Gomez-Suescun, Jorge, Singh, Anurag, Malhotra, Harish“…Propensity score matching was performed for gender, performance status, and history of prior lung cancer. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto